Skip to main content

CORRECTION article

Front. Pharmacol., 12 April 2023
Sec. Pharmacology of Anti-Cancer Drugs
Volume 14 - 2023 | https://doi.org/10.3389/fphar.2023.1200491

Corrigendum: Adenosine kinase on deoxyribonucleic acid methylation: Adenosine receptor-independent pathway in cancer therapy

This article is a correction to:

  1. Adenosine Kinase on Deoxyribonucleic Acid Methylation: Adenosine Receptor-Independent Pathway in Cancer Therapy

    1. Read original article
Hao-Yun Luo&#x;Hao-Yun Luo1†Hai-Ying Shen,&#x;Hai-Ying Shen2,3†R. Serene Perkins,R. Serene Perkins4,5Ya-Xu Wang Ya-Xu Wang1*
  • 1Department of Gastrointestinal and Anorectal Surgery, The Second Affiliated Hospital of Chongqing Medical University, Chongqing, China
  • 2Department of Neuroscience, Legacy Research Institute, Portland, OR, United States
  • 3Integrative Physiology and Neuroscience, Washington State University, Vancouver, WA, United States
  • 4Legacy Tumor Bank, Legacy Research Institute, Portland, OR, United States
  • 5Mid-Columbia Medical Center, The Dalles, OR, United States

A Corrigendum on
Adenosine kinase on deoxyribonucleic acid methylation: Adenosine receptor-independent pathway in cancer therapy

by Luo H-Y, Shen H-Y, Perkins RS and Wang Y-X (2022). Front. Pharmacol. 13:908882. doi: 10.3389/fphar.2022.908882

In the published article, there was an error in the Affiliation for Authors Hao-Yun Luo and Ya-Xu Wang. Instead of “1Chongqing Medical University, Chongqing, China, 2Department of Gastrointestinal and Anorectal Surgery, The Second Affiliated Hospital of Chongqing Medical University, Chongqing Medical University, Chongqing, China”, the correct affiliation is “1Department of Gastrointestinal and Anorectal Surgery, The Second Affiliated Hospital of Chongqing Medical University, Chongqing, China”.

The authors apologize for this error and state that this does not change the scientific conclusions of the article in any way. The original article has been updated.

Publisher’s note

All claims expressed in this article are solely those of the authors and do not necessarily represent those of their affiliated organizations, or those of the publisher, the editors and the reviewers. Any product that may be evaluated in this article, or claim that may be made by its manufacturer, is not guaranteed or endorsed by the publisher.

Keywords: DNA methylation, adenosine, receptor-independent pathway, adenosine kinase, ADK isoforms, ADK inhibitor, cancer therapy

Citation: Luo H-Y, Shen H-Y, Perkins RS and Wang Y-X (2023) Corrigendum: Adenosine kinase on deoxyribonucleic acid methylation: Adenosine receptor-independent pathway in cancer therapy. Front. Pharmacol. 14:1200491. doi: 10.3389/fphar.2023.1200491

Received: 05 April 2023; Accepted: 06 April 2023;
Published: 12 April 2023.

Approved by:

Frontiers Editorial Office, Frontiers Media SA, Switzerland

Copyright © 2023 Luo, Shen, Perkins and Wang. This is an open-access article distributed under the terms of the Creative Commons Attribution License (CC BY). The use, distribution or reproduction in other forums is permitted, provided the original author(s) and the copyright owner(s) are credited and that the original publication in this journal is cited, in accordance with accepted academic practice. No use, distribution or reproduction is permitted which does not comply with these terms.

*Correspondence: Ya-Xu Wang, 300897@hospital.cqmu.edu.cn

†These authors have contributed equally to this work

Disclaimer: All claims expressed in this article are solely those of the authors and do not necessarily represent those of their affiliated organizations, or those of the publisher, the editors and the reviewers. Any product that may be evaluated in this article or claim that may be made by its manufacturer is not guaranteed or endorsed by the publisher.